Replies to post #249718 on Biotech Values

[DewDiligence]

RNAC -36% on purportedly-positive phase-2b data in MG:

https://www.globenewswire.com/news-release/2024/07/02/2907273/0/en/Cartesian-Therapeutics-Announces-Positive-Topline-Results-from-Phase-2b-Trial-of-Descartes-08-in-Patients-with-Myasthenia-Gravis.html

RNAC is the product of a 2023 reverse-merger (#msg-173210464.